The invention relates to a
Chinese traditional patent medicine (the
trade name being Rehmanniae Diabetes
Capsule) for treating diabetes. The
medicine comprises the following raw materials by weight portion: 30 to 60 portions of dwarf lilyturf tuber (also named dwarf lilyturf root), 30 to 60 portions of
asparagus root (also named
asparagus), 40 to 70 portions of figwort (also named radix scrophulariae), 70 to 150 portions of
coptis root, 50 to 100 portions of oriental waterplantain
rhizome, 20 to 50 portions of tuckahoe, 70 to 150 portions of cortex lycii radicis, 50 to 100 portions of
tragacanth (also named radix astragali), 40 to 100 portions of cornus (also named cornus pulp), 30 to 60 portions of medlar, 50 to 100 portions of dry rehmanniae (also named fresh rehmanniae), 40 to 90 portions of prepared radix rehmanniae (also named prepared
rhizome of rehmanniae), 20 to 60 portions of
trichosanthin, 30 to 80 portions of panax, 20 to 40 portions of pilose
antler and 50 to 100 portions of white
muscardine silkworm. The
Chinese traditional patent medicine plays a role in enhancing the sensibility of
human body against
insulin, reducing
blood sugar and blood fat, regulating viscera and nourishing
liver and kidney; moreover, the
Chinese traditional patent medicine has scientific manufacturing process and can extract effective ingredients in raw materials.